Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
100.00
-1.50 (-1.48%)
Apr 2, 2025, 1:30 PM CST

Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 12.61 billion as of April 4, 2025. Its market cap has decreased by -44.80% in one year.

Market Cap
12.61B
Enterprise Value
10.52B
Revenue
32.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
100.00

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y6 Apr 20202 Apr 2025Range ▾Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25010.00B20.00B30.00B40.00B50.00B12.61B

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 12.61B, an increase of 42.17%. That is a compound annual growth rate of 4.41%.

History

DateMarket Cap% Change
Apr 2, 202512.61B-12.27%
Dec 31, 202414.37B-31.28%
Dec 29, 202320.91B-42.13%
Dec 30, 202236.13B16.16%
Dec 30, 202131.10B17.15%
Dec 31, 202026.55B222.07%
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition